Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,607 total articles

Aurora Mobile Showcases at Tourism EXPO Japan 2026: How AI is Solving the Travel Industry’s Staffing Crisis

Aurora Mobile Showcases at Tourism EXPO Japan 2026: How AI is Solving the Travel Industry’s Staffing Crisis

Aurora Mobile Limited (NASDAQ: JG) showcased its AI-driven customer engagement and marketing technology solutions at Tourism EXPO Japan 2026, demonstrating how its platforms—EngageLab, GPTBots.ai, and Modellix.ai—help the tourism industry overcome staff shortages and operational inefficiencies. Their AI solutions offer 24/7 multilingual customer su…

Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

Moleculin Biotech announced the publication of a peer-reviewed analysis in Frontiers in Cardiovascular Medicine showing no clinical or subclinical cardiotoxicity associated with its anthracycline drug, Annamycin, in a pooled analysis of five clinical trials involving 90 patients. Independent evaluation by the Cleveland Clinic supported these findin…

Eldorado Gold Announces Completion of Skouries Mine Energization

Eldorado Gold Announces Completion of Skouries Mine Energization

Eldorado Gold Corporation announced the successful energization of its Skouries mine in Greece following connection to the national grid, marking a major milestone toward ramping up operations. With first copper-gold concentrate production achieved, Eldorado advances toward expected commercial production in Q4 2026, aiming to produce 140,000 ounces…

BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer

BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer

BlossomHill Therapeutics presented preclinical data demonstrating that their novel pan-KRAS inhibitor BH-501284 exhibits potent and prolonged inhibition of KRAS mutations with deep and durable antitumor activity across multiple cancer models. Designed with a unique Switch-II scaffold and pseudo-irreversible binding, BH-501284 aims to overcome limit…

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab

Tiziana Life Sciences has dosed the first participants in the Phase 2a BANYAN clinical trial studying intranasal foralumab for ALS. The trial aims to evaluate safety, tolerability, and the drug's biological effects on regulatory T cell pathways in ALS patients. Foralumab is a novel, fully human anti-CD3 monoclonal antibody administered intranasally…

Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate

Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate

Arvinas, Inc., a clinical-stage biotech company specializing in targeted protein degradation, announced dosing the first patient in its Phase 1/2 trial of ARV-6723, its first immuno-oncology candidate. ARV-6723 is an oral PROTAC designed to degrade HPK1, a negative regulator of immune activation, aiming to enhance antitumor immune responses in adva…

Churchill Downs Incorporated Announces Closing of Amended and Extended Credit Facility and New Term Loan B

Churchill Downs Incorporated Announces Closing of Amended and Extended Credit Facility and New Term Loan B

Churchill Downs Incorporated announced the closing of an amended and extended senior secured credit facility along with a new $500 million Term Loan B due in 2033. The amendment extends the maturity dates on revolving and term loans to 2031, and the new Term Loan B will be used to repay existing loans, cover fees, and support general corporate purp…

Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026

Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026

Sagimet Biosciences announced a virtual Key Opinion Leader event detailing positive 52-week data from its license partner Ascletis' Phase 3 open-label extension trial of denifanstat in China for moderate to severe acne. The company also outlined plans to initiate its own U.S. Phase 3 AURORA clinical trial in Q4 2026 to further evaluate denifanstat'…

Kandi Technologies’ China Battery Exchange Secures Follow-On Order for CATL Heavy-Truck Battery Swap Stations

Kandi Technologies’ China Battery Exchange Secures Follow-On Order for CATL Heavy-Truck Battery Swap Stations

Kandi Technologies Group, Inc., through its subsidiary China Battery Exchange, has secured a second batch order for heavy-truck battery swap station equipment from QIJI Energy, a CATL subsidiary. This follows recent agreements and production milestones, marking a transition from product validation to commercial deployment in the heavy-truck battery…

Armlogi Holding Corp. Reports Fiscal Year 2026 Financial Results; Warehousing Services Revenue Grows 21.9% to $77.1 Million

Armlogi Holding Corp. Reports Fiscal Year 2026 Financial Results; Warehousing Services Revenue Grows 21.9% to $77.1 Million

Armlogi Holding Corp. reported fiscal 2026 revenues of $185.8 million with warehousing services up 21.9% to $77.1 million, making up 41.5% of total revenue. Transportation services revenue declined 14.5%. Gross profit turned positive at $0.4 million compared to a loss last year, but net loss widened to $20.9 million. The company fully settled conve…

B2Gold Provides Operations Update for the Goose Mine and Announces Drill Results at the Back River Gold District

B2Gold Provides Operations Update for the Goose Mine and Announces Drill Results at the Back River Gold District

B2Gold Corp. has provided an operational update on its Goose Mine highlighting the commissioning of a new mobile crushing plant achieving targeted throughput following fire damage earlier in 2026. The company is on track to meet its annual gold production guidance of 170,000 to 200,000 ounces. Additionally, positive results from the 2026 exploratio…

Bimergen Energy Board Authorizes Warrant Buyback Program

Bimergen Energy Board Authorizes Warrant Buyback Program

Bimergen Energy Corporation, a U.S. developer and operator of utility-scale battery energy storage systems, has authorized an open-market warrant repurchase program. This initiative aims to strategically deploy capital to reduce future equity dilution and optimize the company's equity structure, potentially enhancing long-term value for common stoc…